Skip to main content
. 2023 Nov 6;23:572. doi: 10.1186/s12905-023-02746-w

Table 3.

Antibiotic susceptibility of the bacterial isolates

Antibiotic Bacterial isolates n (%) Total N = 107
S.aureus n = 52(%) S.agalactieae n = 3 (%) Kleb spp n = 32 (%) E.coli n = 4 (%) E. fecalis n = 16 (%)
Amoxicillin S 22(42.3) 2(66.7) Not tested 2(50) 13(81.3) 39 (36.5)
R 30(57.7) 1(33.3) Not tested 2(50) 3(18.7) 68 (63.5)
Amoxicillin/Clavulanate S 41(78.8) 3(100) 22(68.8) 4(100) 13(81.3) 83(77.6)
R 11(21.2) 0(00) 10(31.2) 0(00) 3(18.7) 24(22.7)
Ciprofloxacin S 42(80.8) Not tested 26(81.3) 3(75) 16(100) 87 (81.3)
R 10(19.2) Not tested 6(18.7) 1(25) 0(00) 20 (18.7)
Ceftriaxone S 46(88.5) 3(100) 3(9.4) 4(100) 12(75) 68 (63.6)
R 6(11.5) 0(00) 29(90.6) 0(00) 4(25) 39 (26.4)
Cefixime S 41(78.8) 3(100) 21(65.6) 3(75) 14(87.5) 82 (76.6)
R 11(21.2) 0(00) 11(34.4) 1(25) 2(12.5) 25 (23.4)
Cefuroxime S 48(92.3) 3(100) 27(84.4) 4(100) 15(93.8) 97 (90.7)
R 4(7.7) 0(00) 5(15.6) 0(00) 1(6.2) 10 (9.3)
Erythromycin S 11(21.2) 0(00) Not tested Not tested 3(18.7) 14 (19.7)
R 41(78.8) 3(100) Not Tested Not tested 13(81.3) 57 (80.3)
Gentamycin S 38(73.1) 3(100) 27(84.4) 3(75) 13(81.3) 84 (78.5)
R 14(26.9) 0(00) 5(15.6) 1(25) 3(18.7) 23 (21.5)
Tetracycline S 3(5.8) 1(33.3) 4(12.5) 0(00) 1(6.2) 9 (8.4)
R 49(94.2) 2(66.7) 28(87.5) 4(100) 15(93.8) 98 (91.6)
Doxycycline S 7(13.5) 1(33.3) 6(18.7) 0(00) 1(6.2) 15 (14)
R 45(86.5) 2(66.7) 26(81.3) 4(100) 15(93.8) 92 (86)
Azithromycin S 22(42.3) 2(66.7) 8(25) 2(50) 12(75) 46 (43)
R 30(57.7) 1(33.3) 24(75) 2(50) 4(25) 61 (67)

S Sensitive, R Resistant, Kleb spp Klebsiella pneumoniae, S. aureus Staphylococcus aureus, S. agalactiae Streptococcus agalactiae, E. coli Escherichia coli, E. faecalis Enterococcus faecalis